Sr. Director, Financial Planning & Analysis - Pleasanton, CA

Calyxo, Inc. is a medical device company headquartered in Pleasanton, California, USA. The company was founded in 2016 to address the profound need for improved kidney stone treatment. Kidney stone disease is a common, painful condition that consumes vast amounts of healthcare resources each year. Our team is led by executives and investors with a proven track record of commercializing paradigm-shifting devices to meet unmet needs within urology.

Are you ready to change the future of kidney stone treatment? We are seeking high achievers who want to be part of a dynamic team working in a fun, diverse atmosphere.

Summary:  

The Sr. Director, Financial Planning & Analysis (FP&A) plays a pivotal role in shaping the company’s financial strategy, driving enterprise-wide performance, and supporting executive decision-making in a fast-growing medical device organization. This role serves as a key strategic partner to the VP Finance, CFO and executive leadership team, leading financial planning, forecasting, and long-range strategy while providing actionable insights that influence the direction of the business. 

The Sr. Director will own enterprise financial planning processes, enhance financial infrastructure to support scale, and lead high-impact strategic initiatives including capital allocation, investment prioritization, and potential IPO readiness. The ideal candidate brings deep financial expertise, executive presence, and a proven track record of leading finance functions in dynamic, high-growth environments. 

In This Role, You Will 

Enterprise Financial Planning Leadership 

• Partner with the VP of Finance and CFO to lead and evolve enterprise-wide financial planning across P&L, Balance Sheet, and Cash Flow, driving improved forecast accuracy, financial visibility, and operational alignment. 
• Own and lead key planning cycles including: 
• Annual Operating Plan (AOP): Enterprise-wide budget across revenue, operating expenses, headcount, and capital expenditures 
• Quarterly Forecasting: Rolling 12–18 month outlook with executive-level insights and risk/opportunity identification 
• Long-Range Planning (LRP): 3–5 year strategic financial plans incorporating scenario modeling, capital strategy, and growth initiatives 
• Establish scalable planning processes and frameworks to support rapid organizational growth and increased complexity 

Executive Reporting & Strategic Insights 

• Own executive and Board-level financial reporting, including dashboards, KPI frameworks, variance analysis, and Board of Directors materials 
• Provide forward-looking insights and recommendations that directly influence executive decision-making and company strategy 
• Synthesize complex financial and operational data into clear, actionable narratives for senior leadership and investors 

Strategic Business Partnership 

• Serve as a senior finance partner to executive leadership across Sales, R&D, Clinical, Market Access, Quality & Regulatory, Operations, Marketing, and G&A 
• Provide financial leadership for: 
• Product launches, clinical trials, and commercialization strategies 
  Market expansion, pricing strategy, and reimbursement dynamics 
• Resource allocation and capital investment decisions 
• Influence strategic decisions including portfolio prioritization, go-to-market strategies, and long-term growth initiatives 

Financial Close & Reporting Alignment 

• Provide oversight and alignment wi